Bright Minds Biosciences Inc (DRUG)
$54.98 -3.02% Close Oct 30, 2026 Live
Bright Minds Biosciences stock today
Bright Minds Biosciences closed at $54.98 on October 30, 2026, down 3.02% on the day. Over the past year it returned +0.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $539 million.
$60.00$80.00
NovJan 2026MarMayJulSep
| Period | DRUG | S&P 500 (SPY) |
|---|---|---|
| 1 month | +10.4% | -0.9% |
| 3 months | -26.3% | +2.1% |
| Year to date | -29.5% | +11.7% |
| 1 year | +0.9% | +12.4% |
| 3 years | +4,034% | +88.5% |
| 5 years | +54.4% | +76.0% |
Key statistics
- Market value
- $539M
- 52-week range
- $48.25 to $95.98
About Bright Minds Biosciences
Develops psychedelic-assisted therapies and compounds for mental health conditions.
Sector: Health Care
More on Bright Minds Biosciences
- Returns: what $1,000 became$1,000 five years ago is $1,544 today
No forecast, no recommendation. This page describes Bright Minds Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.